{"id":"W2980171540","doi":"10.1182/blood.v122.21.6.6","title":"Head-To-Head Comparison Of Obinutuzumab (GA101) Plus Chlorambucil (Clb) Versus Rituximab Plus Clb In Patients With Chronic Lymphocytic Leukemia (CLL) and Co-Existing Medical Conditions (Comorbidities): Final Stage 2 Results Of The CLL11 Trial","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Interim analysis; Obinutuzumab; Rituximab; Chlorambucil; Chronic lymphocytic leukemia; Surgery; Oncology; Gastroenterology; Randomized controlled trial; Chemotherapy; Leukemia; Cyclophosphamide; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006563898,0.0004134996,0.001331231,0.0002912679,0.0001830358,0.00004484191,0.0005286162,0.0003403505,0.0002714993],"category_scores_gemma":[0.001958429,0.0003056949,0.000152431,0.0007177295,0.0009706127,0.0001643456,0.0003400011,0.0007236772,0.00004201963],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.04414939,"about_ca_system_score_gemma":0.05733548,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01935273,"about_ca_topic_score_gemma":0.004502008,"domain_scores_codex":[0.9946154,0.0002508406,0.00142896,0.0006800861,0.002170991,0.0008537249],"domain_scores_gemma":[0.9964143,0.001196106,0.0005018797,0.00100946,0.0003936641,0.000484593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8751612,0.01388276,0.03563919,0.01001033,0.003440881,0.001082852,0.01884724,0.01295744,0.001238943,0.001488804,0.0139578,0.0122926],"study_design_scores_gemma":[0.9309334,0.006786196,0.02230958,0.001601117,0.000316889,0.00005680696,0.0006132732,0.03445088,0.002082074,0.00001477802,0.0004554852,0.0003795843],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944425,0.0002303077,0.0000109243,0.0001108481,0.0002877092,0.002965519,0.000293589,0.00005100599,0.001607593],"genre_scores_gemma":[0.998684,0.00002537872,0.0001618262,0.00006602353,0.0002354407,0.0001810093,0.0002133627,0.00006005772,0.0003729206],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05577218,"threshold_uncertainty_score":0.9999395,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07089950402949753,"score_gpt":0.3653070094932137,"score_spread":0.2944075054637162,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}